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Abstract
Background: Reading disability (RD) is a common syndrome with a large genetic component.
Chromosome 6 has been identified in several linkage studies as playing a significant role. A more
recent study identified a peak of transmission disequilibrium to marker JA04 (G72384) on
chromosome 6p22.3, suggesting that a gene is located near this marker.
Results: In silico cloning was used to identify possible candidate genes located near the JA04
marker. The 2 million base pairs of sequence surrounding JA04 was downloaded and searched
against the dbEST database to identify ESTs. In total, 623 ESTs from 80 different tissues were
identified and assembled into 153 putative coding regions from 19 genes and 2 pseudogenes
encoded near JA04. The identified genes were tested for their tissue specific expression by RT-
PCR.
Conclusions: In total, five possible candidate genes for RD and other diseases mapping to this
region were identified.
Background
Reading disability (RD), or dyslexia, is a common syn-
drome with a significant genetic component. Genetic link-
age studies have identified five potential RD loci located
on chromosomes 1 [1,2], 2 [3,4], 6 [5–9], 15 [7,10] and
18 [11]. The linkage to 6p has been the most often repro-
duced in independent samples with five studies showing
peaks of linkage to different regional marker sets [5–9].
We recently constructed a BAC/PAC contig of the 6p RD
locus [12] and identified the precise location and order of
29 short tandem repeat (STR) markers spanning this
region [13]. A subsequent study with this new marker
panel identified a peak of transmission disequilibrium at
marker JA04 (G72384) [14].
We searched the expressed sequence tag (EST) database,
dbEST http://www.ncbi.nlm.nih.gov/dbEST/index.html,
with the genomic sequence corresponding to the peak of
transmission disequilibrium at marker JA04. ESTs are par-
tial and usually incomplete cDNA sequences prepared
from various tissues. Presently, nearly four million ESTs
(dbEST release 04/19/02) are catalogued in dbEST repre-
senting about 80% or more of all human genes with at
least one representative entry [15]. While not every gene is
accounted for in dbEST, computer database searching,
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also known as in silico cloning, can identify new genes
without actual physically manipulating DNA. These types
of analyses can also characterize intron-exon boundaries,
splice variants, tissue specific expression levels, and gene
homologies [16]. Furthermore, clustering ESTs together to
form a contiguous sequence can predict putative open
reading frame (ORFs). The first map of the human
genome, which contained over 30,000 genes, was gener-
ated by mapping EST clusters to human-hamster radiation
hybrid cell lines [17]. Despite their wide-ranging utility,
ESTs have two inherent drawbacks: (1) they are based on
single sequence reads making them vulnerable to
sequencing errors, and (2) they are generated from cDNA
libraries that may contain unexpressed or incompletely
spliced sequences derived from heteronuclear RNA or
other artifacts. The clustering of ESTs to form ORFs could
contain both expressed and unexpressed sequences and
should be treated with caution. Fortunately, the high
redundancy of entries in dbEST permits the alignment of
multiple ESTs for most genes thus diminishing the effects
of these drawbacks.
To identify candidate genes for RD and other disorders
mapping to this region we downloaded and searched the
two million base pairs of genomic sequence surrounding
the peak of transmission disequilibrium. In addition to
RD, risk loci for Behçet's disease [18], inflammatory
bowel disease (IBD3) [19,20], hypotrichosis simplex
(HSS) [21], insulin dependent type 1 diabetes mellitus
[22], attention deficit hyperactivity disorder (ADHD) [23]
and schizophrenia [24] have all been assigned to this gen-
eral chromosomal location by genetic linkage analysis.
Using in silico cloning we identified a total of 19 genes and
2 pseudogenes and mapped their precise physical location
and direction of transcription. The expression pattern of
each gene was characterized by examining the number of
ESTs identified from various tissues as well as by qualita-
tive RT-PCR with RNA from 20 different human tissues.
This study also allowed us to test the usefulness of in silico
cloning to identify and map new genes in a focussed
region of the genome.
Results
Using the blastc13 server at NCBI, we performed in silico
cloning studies of the 6p RD locus to identify coding
regions. In total, 623 ESTs from 80 different tissues were
identified and aligned to 2 Mb of genomic sequence.
These searches captured 157 putative coding regions from
19 genes and 2 pseudogenes concentrated in the central
1200 Kb shown in detail in Figure 1 with base pair 1 start-
ing at the 5-prime end of FLJ12671 and ending 1 Kb cen-
tromeric to the 3-prime end of RPS10. Short tandem
repeat marker JA04, which identified the peak of transmis-
sion disequilibrium for RD phenotypes in previous stud-
ies [14], is at 540 Kb. The most telomeric 200 Kb and the
most centromeric 600 Kb of genomic sequence are void of
coding regions. Intergenic distances range from less than
1 Kb (KIAA0319 and TRAF) to 110 Kb (HNRPA1 and
P24). Cytokeratin 8, transcribed telomere to centromere,
is located in the intron between exons 1 and 2 of
KIAA0319 (transcribed centromere to telomere). Table 1
lists the genes identified in Figure 1, their size in Kb, the
NCBI accession number for the corresponding mRNA or
cDNA, number of exons, genomic mapping source, and
putative function.
Thirteen genes were previously mapped to this region
(RU2AS, MRS2L, GPLD1, SSADH, KIAA0319, TRAF,
HT012, FLJ12619, Geminin, KIAA0386, Cyclophilin A,
CMAH, and NUP50) and are present on the NCBI acces-
sion view (NT_017021) of 6p21.3-22. Our in silico studies
identified an additional six genes (RPS10, FLJ12671,
UBE2D2, AP3, Cytokeratin 8, and P24) and two pseudo-
genes (HNRPA1 and ASSP2) not represented on
NT_017021. In addition we identified a putative fifth
exon for P24 from hypothalamus (BG715502) and pineal
gland (AA363698) cDNA libraries, located between exons
2 and 3 in the 5-prime untranslated region and flanked by
non-traditional splice donor and acceptor bases [25]. The
novel exon was not present in the full-length mRNA
sequence (AF418980).
The functions of the newly identified genes were inferred
by their similarity to other known genes identified in the
BLAST searches. Ribosomal protein L21 (RPS10) is 95%
identical to the genomic and mRNA sequences of a
known ribosomal gene. RPS10 is one of the many pro-
teins that make up the ribosome macromolecule. Other
highly homologous genes of RPS10 are RPS5, RPS9,
RPS29, RPL5, RPl27a, and RPL28 [26]. FLJ12671s a hypo-
thetical gene with an unknown function identified by the
NEDO human cDNA-sequencing project [27]. Blasting
the FLJ12671 sequence against the nr database also iden-
tified hits on chromosomes 1 and 11, suggesting that this
gene has been duplicated on several chromosomes. Ubiq-
uitin conjugating enzyme E2D2 (UBE2D2) is a protein
that targets abnormal or short-lived proteins for degrada-
tion by the 26S proteasome [28]. The EST sequences iden-
tified for the UBE2D2 gene on chromosome 6 are 93%
identical to the human UBC4/5 gene located on chromo-
some 5 suggesting that this gene could be a duplicate as
well. Adapter-related protein complex 3 (AP3) may be
involved in intracellular protein transport [29]. Cytokera-
tin 8 is 95% identical to both the genomic and mRNA
sequences of keratin. Vesicular membrane protein (P24),
a previously characterized but unmapped gene [30] has
been localized in intracellular organelles of highly differ-
entiated neural cells and may have a role in the neural
organelle transport system. ASSP2 is one of 12 pseudo-
genes of argininosuccinate synthetase encoded on 10BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/25
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chromosomes with the only functional sequence residing
on chromosome 9 [31]. Heterogeneous nuclear ribonu-
cleoprotein A1 (HNRPA1) is also a pseudogene with three
other copies on chromosomes 3, 13, and 20 [32]. The
copy on chromosome 12q13.1 is thought to encode the
gene responsible for the functional HNRPA1, which
serves as a carrier for RNA during export to the cytoplasm
[33].
The results of the qualitative RT-PCR, though not quanti-
tative, were useful for characterizing the pattern of tissue
expression (Figure 2). While most genes were about
equally represented in the mRNAs of the twenty tissues in
the panel, three genes, P24, NAD (+)-dependent succinic
semialdehyde dehydrogenase (SSADH), and KIAA0319
had exceptional patterns. P24 was almost exclusively
expressed in brain by RT-PCR, correlating with the origin
of all 29 publicly accessible ESTs from brain cDNA librar-
ies (Figure 2). RT-PCR suggested that the expression of
SSADH was greatest in brain, though it was ubiquitously
expressed in all tissues tested. Correspondingly, only 5 of
38 SSADH ESTs accessible on public domain servers were
from brain cDNA libraries, with the remainder of mixed
origin. KIAA0319 had strong signal from brain and cere-
bellum mRNA, reflected by the 10 of 29 publicly accessi-
ble ESTs originating from brain cDNA libraries.
Discussion
The primary goal of this study was to identify candidate
genes surrounding the peak of transmission disequilib-
rium for RD on chromosome 6p and to characterize their
patterns of expression. A secondary goal was to investigate
the usefulness of the in silico approaches and specifically
the dbEST database to identify and map new genes.
We identified 19 genes within 2 Mb of the peak of trans-
mission disequilibrium – but are some better candidates
for RD than others? The patterns of tissue expression as
Transmission disequilibrium and genetic linkage analyses of the 6p21.3 reading disability locus, regional STR markers and tran- scription map Figure 1
Transmission disequilibrium and genetic linkage analyses of the 6p21.3 reading disability locus, regional STR 
markers and transcription map. At the top of the figure is the result of the DeFries-Fulker linkage (T Score, solid line), and 
QTDT linkage disequilibrium (chi-square, dashed line) [14]. The location and order of the 29 STRs are shown below which 
identify a peak of transmission disequilibrium at marker JA04. Below the markers is a detailed representation of 1.2 Mb sur-
rounding marker JA04. The 19 genes and 2 pseudogenes encoded in this region are shown with the telomere on the left and 
centromere on the right and their position and direction of transcription indicated by the arrows.
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profiled by RT-PCR and the frequency with which ESTs
originated from brain cDNA libraries (Figure 2), serve to
highlight five genes that are highly expressed in the brain:
P24, SSADH, GPLD1, KIAA0386, and KIAA0319. Of these
five, only one gene, SSADH, has been associated with a
brain related phenotype. Two frameshift mutations, a G-
to-T transversion in the intron 9 splice donor site, and a
G-to-A transition in the intron 5 splice donor site, cause
an exon to be skipped resulting in abnormal metabolism
of GABA, an important neurotransmitter in the brain. The
handful of described cases were originally diagnosed by
anomalous GABA metabolites in the urine associated with
developmental and speech delays, hyporeflexia, and
behavioral problems including mild autism with clinical
variation between affected family members [34]. There is
no data, however, that links GABA or GABA metabolism
to specific defects of reading independent of IQ. None of
the other genes highly expressed in brain have associated
diseases or clinical phenotypes. GPLD1 selectively hydro-
lyzes inositol phosphate linkages in vitro, releasing the
protein bound to the plasma membrane via a glycosyl-
phosphatidylinositol anchor into the cytosol [35]. P24 is
a neuron specific membrane protein localized in intracel-
lular organelles of highly differentiated neural cells and is
involved in neural organelle transport. KIAA0386 encodes
a protein that stimulates the formation of a non-mitotic
multinucleated syncytium from proliferative cytotro-
phoblasts during trophoblast differentiation [36].
KIAA0319 encodes a protein of unknown function [37].
While HT012, an uncharacterized hypothalamus protein,
could also be considered as a possible candidate gene, RT-
PCR and EST searches (1 of 18 from brain cDNA libraries)
do not suggest a high level or selective expression in the
brain.
The in silico studies also identified candidate genes for
other diseases that map to this region. The five brain can-
didate genes described above for RD are also reasonable
candidates for the neurobehavioral disorders schizophre-
nia and ADHD. HSS results in the complete loss of scalp
hair in childhood. Betz et al [21] described evidence for
linkage to HSS with markers spanning D6S276 (400 Kb
telomeric of JA04) through D6S1607 (5.6Mb centromeric
of JA04). Neither the RT-PCR results nor the tissue origin
for any single gene suggests any best candidates among
the 19. Behçet's disease is an autoimmune disorder
characterized by a systemic vasculitis that affects the
joints, all sizes and types of blood vessels, the lungs, the
central nervous system, and the gastrointestinal tract [38].
There is evidence for linkage with markers spanning
Table 1: Genes encoded within 2 Mb of JA04 in order from telomere (top) to centromere.
Gene Gene Size (kb) MRNA Accession # # of Exons Mapping Source Function
FLJ12671 15.885 NM_030980 3 This paper Function unknown
HNRPA1 
(pseudogene)
1.813 XM_031157 1 This paper Functions as carriers for RNA during export to the 
cytoplasm
P24 21.142 AF418980 5 This paper Transmembrane protein; may have a role in vesicular 
trafficking
RU2AS 79.995 AF181722 7 [46] Cellular defense response
MRS2L 20.629 XM_041317 11 NT_017021a Transporter protein
GPLD1 61.339 XM_041310 25 [47] Hydrolyzes inositol-PO4 linkage in proteins anchored by 
phosphatidylinositol glycans
SSADH 39.639 NM_001080 10 [48] Required for 4-aminobutyric acid degradation
KIAA0319 102.051 XM_011367 21 NT_017021a Function unknown
Cytokeratin 8 2.206 XM_069402 2 This paper Regulation of exocrine pancreas homeostasis
TRAF 16.902 AF223469 7 [49] Inhibits NF-KappaB activation
HT012 34.662 AF220186 3 NT_017021a Uncharacterized hypothalamus protein
FLJ12619 14.192 XM_041290 5 NT_017021a Function unknown
AP3 1.667 BC000804 3 This paper May be involved in intracellular protein transport
Geminin 11.086 NM_015895 9 NT_017021a Inhibits DNA replication during cell cycle S, G2, and M 
phase
KIAA0386 106.682 AB002384 23 NT_017021a Stimulates the formation of a non-specific multinucleate 
syncytium from proliferative cytotrophoblasts during tro-
phoblast differentiation
Cyclophilin A 0.81 XM_098483 2 NT_017021a May to be involved in protein folding and/or intracellular 
protein transport
ASSP2 (pseudogene) 1.954 XM_000845 1 This paper Catalyzes the ATP-dependent ligation of citrulline to 
aspartate, forms argininosuccinate in the urea cycle
CMAH 56.489 XM_041278 15 [50] Converts the nucleotide sugar donor N-acetylneuraminic 
acid to N-glycolylneuraminic acid
NUP50 1.737 XM_018531 1 NT_017021a Allows bi-directional transport of macromolecules through 
the nuclear envelope
UBE2D2 1.732 XM_030770 1 This paper Modifies proteins with ubiquitin for degradation
RPS10 1.428 XM_069039 2 This paper Ribosomal protein
a The gene has been mapped on NCBI accession NT_017021 but no citation is presentBMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/25
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nearly 28 Mb of 6p with JA04 in the middle [18]. Candi-
date genes for Behçet's would include those expressed in
lymphocytes or perhaps bone marrow such as AP3 and
FLJ12671 and other immune related genes such as TRAF
and RU2AS. These genes may also serve as candidates for
other autoimmune disorders that map to this region such
as IBD3.
Overall the in silico method for identifying genes in a spe-
cific genomic region worked well here, yielding a reason-
able gene density of one per 95 kb. This method is highly
dependent upon the quality of the information in dbEST.
Any contamination from non-coding DNA, bacterial
DNA, cDNA from other species, vectors or mitochondria
DNA could generate false gene assignments. Fortunately,
the high redundancy of EST hits in dbEST increased our
confidence that any identification was likely physiologic
and that the searches were sensitive. It is possible how-
ever, that our in silico approach may have missed some
genes, in particular those with small ORFs and/or large 5-
prime and/or 3-prime UTRs [39]. As dbEST expands over
the next few years, new genes may be identified with
repeated in silico searches, or with biophysical approaches
such as cDNA hybridization [40], exon trapping [41] and
amplification [42], or by identification of evolutionary
conserved sequences [43] and HTF islands [44].
Conclusion
In summary, we examined 2 Mb surrounding the trans-
mission disequilibrium peak with RD at short tandem
repeat marker JA04 on chromosome 6p. In silico searches
of the dbEST database identified 19 possible candidate
genes. While tissue expression patterns suggest five candi-
dates that are highly expressed in brain – one with a
known association with neurological disease – neither the
RT-PCR data nor the EST information can absolutely rule
out any of the 19 as culpable candidates. We conclude
therefore that in silico cloning is a powerful and effective
technique for quickly identifying existing and novel
genes, which can then be used to develop cDNA single
nucleotide polymorphism markers (cSNPs) for pinpoint-
ing a more precise location of the 6p RD gene, and other
disease genes that map to this region.
Methods
In silico cloning
The two million base pairs of index genomic sequence
surrounding marker JA04 was downloaded from the
NCBI website (accession number NT_017021). A perl
script was written to parse the sequence into 200 files each
containing 10 Kb segments in FASTA format. Repeat
sequences were masked with the RepeatMasker program
(RepeatMasker at http://ftp.genome.washington.edu/RM/
RepeatMasker.html). Each masked file was sent to the
blastc13 server as a query for searching the dbEST data-
base using the BLAST algorithm [45]. Only ESTs with an
identity of 93% or greater were considered; all other hits
were discarded. Surviving ESTs were then used to search
the nr database to identify parental cDNA or mRNA
matches, which assembled 623 non-overlapping ESTs
into 21 gene or pseudogene antecedents. The BLAST
search of nr also showed hits against chromosome 6 BAC
or PAC sequence. ESTs not mapping to chromosome 6
were also discarded. The final assemblies of EST and
cDNA or mRNA sequences were aligned to the index
NT_017021 genomic sequence using the Martinez
Needleman-Wunsch algorithm in MegAlign (DNA Star,
Lasergene) permitting identification of exon-intron
boundaries, new exons (P24), and the direction of tran-
scription relative to the telomere.
Qualitative PCR
A panel containing human total RNA from 20 different
tissues was purchased from Clontech (BD Biosciences
Clontech). RT-PCR was performed using the RETROscript
first strand synthesis kit for RT-PCR (Ambion). 2µg of
RNA was denatured with 0.5µM of random decamer
RT-PCR analysis of genes within 2 Mb of JA04 Figure 2
RT-PCR analysis of genes within 2 Mb of JA04. The 
results of the qualitative PCR for the 19 genes identified in 
this region. RNA from 20 tissues was used along with a blank 
control (lane 16) for the RT-PCR step. The genes are listed 
on the left along side their corresponding gel. The number of 
ESTs identified in brain libraries is listed on the right along 
with the total number of ESTs for that gene.BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/25
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primers in a total volume of 12µl, and heated to 77°C for
three minutes and placed on ice. First strand cDNA was
then synthesized with the addition of 2µl 10 × RT buffer,
4µl dNTP mix, 1 Unit RNase inhibitor, and 100 Units
MMLV-RT in a total volume of 20µl. The reaction was
incubated for one hour at 44°C, and then 92°C for ten
minutes and then stored at -20°C.
To check the quality of the first strand cDNA, 1µl of cDNA
was used in a PCR reaction to amplify the rig/S15 ribos-
omal gene. 1.5µl of 10 × PCR buffer (Qiagen), 250µM of
each dNTP, 0.5 Units of HotstarTaq polymerase (Qiagen)
and 0.5µM of primer (Ambion) were used in a 15µl reac-
tion. The reaction was denatured for 15 minutes at 95°C,
then ten cycles of 94°C for 30 seconds, 65°C for 30 sec-
onds (-1°C/cycle), and 72°C for 30 seconds, 20 addi-
tional cycles of 94°C for 30 seconds, 55°C for 30 seconds
and 72°C for 30 seconds, and a final extension of 72°C
for ten minutes. PCR reactions were performed in a MJ
Research thermocycler. PCR products were electro-
phoresed on 2% agarose gels.
Primers (primer sequences are listed in Table 2) were
designed to amplify the mRNA sequences of each of the
20 genes identified in the transcript map (Figure 1). Each
amplicon was designed to be between 90 and 150 base
pairs in length. For each amplicon, 1µl of cDNA, 1.5µl of
10 × PCR buffer (Qiagen), 250µM of each dNTP, 0.5 units
of HotstarTaq polymerase (Qiagen) and 0.5µM of primer
(Life Technologies) were used in a 15µl reaction. PCR
reactions were performed as above. One lane (Figure 2,
lane 16) contained water during the RT-PCR step to check
for RNA contamination. Products were electrophoresed
on 2% agarose gels and stained with ethidium bromide.
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